NasdaqCM - Nasdaq Real Time Price USD

electroCore, Inc. (ECOR)

7.92 +0.40 (+5.61%)

As of 9:45:28 AM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026

GlobeNewswire 4d ago

ECOR
+5.61%
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

GlobeNewswire 5d ago

ECOR
+5.61%
electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub

GlobeNewswire 12d ago

ECOR
+5.61%
electroCore to Participate at H.C. Wainwright Global Investment Conference

GlobeNewswire 1mo ago

ECOR
+5.61%
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

GlobeNewswire 1mo ago

ECOR
+5.61%
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

GlobeNewswire 2mo ago

ECOR
+5.61%
electroCore to Participate in Upcoming Investor Conferences

GlobeNewswire 2mo ago

ECOR
+5.61%
electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

GlobeNewswire 3mo ago

ECOR
+5.61%
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

GlobeNewswire 4mo ago

ECOR
+5.61%
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

GlobeNewswire 5mo ago

ECOR
+5.61%
electroCore Announces First Quarter 2026 Financial Results

GlobeNewswire 5mo ago

ECOR
+5.61%
electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge

GlobeNewswire 6mo ago

ECOR
+5.61%

Performance Overview

Return	ECOR	S&P 500 (^GSPC)
YTD	+67.67%	+10.73%
1-Year	+54.10%	+11.11%
3-Year	+22.28%	+81.91%

U.S. markets close in 6h 10m

electroCore, Inc. (ECOR)

electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026

electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub

electroCore to Participate at H.C. Wainwright Global Investment Conference

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

electroCore to Participate in Upcoming Investor Conferences

electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

electroCore Announces First Quarter 2026 Financial Results

electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge